The agreement includes plans for distribution, technology transfer, local manufacturing, new pharmaceutical product development
The global TCIM market is expected to reach nearly US$ 600 billion by 2025
GII is a leading investment firm with assets under management exceeding US$ 3.5 billion with presence across Saudi Arabia, UAE, Europe, USA and India
New platform powered by Opentrons expands lab automation to accelerate scientific discovery
Baxdrostat demonstrated a statistically significant and clinically meaningful reduction of systolic blood pressure compared with placebo
LEQSELVI now available for prescription in U.S. nationwide, offering a new option for eligible patients
Spikevax is now approved for all individuals aged 6 months through 64 years at increased risk for COVID-19 disease
This collaboration marks a significant milestone for Abluva as the company aims to deliver value and innovative solutions in agentic AI security
The company’s largest center for medical device applications, serving the entire Asian market
Subscribe To Our Newsletter & Stay Updated
